Properties (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gene therapy
|
| gptkbp:aimsTo |
provide long-term treatment
|
| gptkbp:associated_with |
patient outcomes
high treatment costs risks and side effects |
| gptkbp:basedOn |
genetic modification
|
| gptkbp:clinicalTrials |
various stages
|
| gptkbp:collaborations |
research institutions and companies
|
| gptkbp:delivers |
corrected gene
|
| gptkbp:developedBy |
biotechnology companies
|
| gptkbp:explores |
other genetic disorders
|
| gptkbp:features |
innovation in healthcare
|
| gptkbp:future_plans |
improve quality of life
|
| gptkbp:has_a_focus_on |
medical research
pharmaceutical research biomedical engineering research |
| gptkbp:has_implications_for |
healthcare_policy
|
| https://www.w3.org/2000/01/rdf-schema#label |
gene therapy for hemophilia
|
| gptkbp:influenced |
patient genetics
|
| gptkbp:involves |
ex vivo and in vivo techniques
injection into the bloodstream |
| gptkbp:is_a |
molecular medicine
|
| gptkbp:is_a_document_that |
hemophilia patients
|
| gptkbp:is_a_subject_of |
clinical guidelines
scientific conferences ethical discussions |
| gptkbp:is_a_symbol_of |
different_hemophilia_types
|
| gptkbp:is_a_time_for |
treatment-resistant patients
|
| gptkbp:is_a_way_to |
genetic diseases
traditional therapies |
| gptkbp:is_displayed_on |
promising results
increase factor levels |
| gptkbp:is_essential_for |
hemophilia_treatment
|
| gptkbp:is_evaluated_by |
long-term safety
|
| gptkbp:is_expected_to |
reduce healthcare burden
transform_hemophilia_management |
| gptkbp:is_funded_by |
government grants
|
| gptkbp:is_governed_by |
health authorities
|
| gptkbp:is_linked_to |
advancements in biotechnology
|
| gptkbp:is_monitored_by |
regulatory agencies
|
| gptkbp:is_part_of |
personalized treatment plans
precision medicine the evolving landscape of medicine the future of genetic medicine the_future_of_hemophilia_care |
| gptkbp:is_studied_in |
animal models
multiple countries |
| gptkbp:is_supported_by |
patient advocacy groups
|
| gptkbp:mayHave |
need for regular factor replacement
|
| gptkbp:produces |
gptkb:severe_hemophilia
other gene therapies. |
| gptkbp:reduces |
bleeding episodes
|
| gptkbp:requires |
patient eligibility assessment
|
| gptkbp:serves |
hemophilia
|
| gptkbp:suitableFor |
a potential cure
|
| gptkbp:targets |
liver cells
|
| gptkbp:ticketingSystem |
intravenous infusion
|
| gptkbp:uses |
viral vectors
|
| gptkbp:was_a_response_to |
limitations of current therapies
|